Copyright 2019, Forbesindia.com

Covid-19: Post-vaccination coronavirus cases miniscule

Data released Wednesday shows that per 10,000 people, the rate of infections among persons who have taken either the first or second dose of Bharat Biotech's Covaxin or Serum Institute's Covishield is extremely low


_slideshow_